390 results on '"Carreras, Enric"'
Search Results
2. EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation
3. Improving the EASIX’ predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantation
4. Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study
5. Reversal of particle Migration for viscoelastic solution at high solvent viscosity
6. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)
7. Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis
8. Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro
9. Prevention of veno-occlusive disease/sinusoidal obstruction syndrome: a never-ending story and no easy answer
10. Influence of silane interfacial chemistry on the curing process of anionic Polyamide 6 in glass reinforced composites
11. Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant
12. Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry
13. Hyponatremia induced by post-transplant cyclophosphamide in allogeneic hematopoietic cell transplantation
14. Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era
15. Estimation of Antibody-Verified Eplet Mismatch Load, 2-Field HLA Resolution vs Imputation in a Large Cohort of European Donors
16. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?
17. An endothelial proinflammatory phenotype precedes the development of the engraftment syndrome after autologous Hct
18. Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide based prophylaxis.
19. Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation
20. Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation
21. Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations
22. The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae
23. Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
24. Progressive endothelial cell damage in correlation with sepsis severity. Defibrotide as a contender
25. The EBMT Handbook
26. Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party
27. How emulsified droplets induce the bursting of suspended films of liquid mixtures.
28. Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.
29. Is sickle cell disease-related neurotoxicity a systemic endotheliopathy?
30. The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium
31. Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis
32. Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group
33. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells
34. Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes
35. Bacterial Bloodstream Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
36. Vascular endothelial syndromes after HCT: 2020 update
37. PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT
38. Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy
39. Surface Probing with Streaming Potential: The Polymer Flooding Scenario
40. Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis
41. Endothelial Dysfunction in Hematopoietic Cell Transplantation
42. Microfluidic channels of adjustable height using deformable elastomer
43. Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation
44. Analysis of the Spanish CCR5-∆32 inventory of cord blood units: lower cell counts in homozygous donors
45. Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program
46. What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance
47. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico
48. Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation
49. Pharmacodynamics of T cell function for monitoring pharmacologic immunosuppression after allogeneic hematopoietic stem cell transplantation
50. Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.